October 24, 2018
Emergent BioSolutions Inc. (NYSE: EBS) today announced, through its subsidiary Adapt Pharma, the launch of two new programs to raise public awareness of the potential risks of opioids and the importan...
October 15, 2018
Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (naloxone HCI) Nasal Spray...
September 24, 2018
Media Campaign Launched to Raise Awareness of NARCAN® Nasal Spray...